Abstract:Depression is a prevalent mental illness, affecting a significant portion of the global population. Recent research has highlighted the crucial role of the gut microbiota in both metabolic and central nervous health. By reviewing literature from various databases, including Pubmed, Science Direct, Web of Science, and Scopus, spanning the years 2005–2023, a comprehensive search was conducted using keywords such as "Depression" and "Gut Microbiota". The gut microbiota acts as a "second brain" in humans and can communicate bidirectionally with the brain through the Brain-gut-microbiota axis pathway. This communication involves the immune and nervous systems. However, there are challenges in detecting and treating depression effectively. To address these limitations, researchers have been exploring the relationship between gut microbiota and depression. Studies have shown that gut microbial metabolites, such as lipopolysaccharides and short-chain fatty acids, can induce pro-inflammatory cytokines that contribute to neuroinflammation and increase the risk of depression. The kynurenine pathway, triggered by gut microbial metabolites, has also been associated with neuroinflammation. Thus, investigating these microbial metabolites can provide insights into depression treatment. This review focuses on analyzing the connection between gut microbial metabolites, inflammation, and depression. It explores novel mechanisms contributing to depression, specifically focusing on the mediation of inflammation through the release of pro-inflammatory cytokines. The objective is to provide valuable insights into the mechanisms underlying depression and to propose potential treatments.

Research progress of neuroendocrine immune inflammation in depression

The mediation of immune activation on serotonin and glutamate systems in pathological process of depression

Reseach progress in neuroinflammation mechanism in depression.

Neuroimmune Advance in Depressive Disorder

Research Progress of Immune Regulation in Antidepressant Treatment

Progress of neuroinflammation mechanism in depression

Research progress of neurobiochemical mechanism of depression

Research progress on the relationship between NLRP3 inflammatory body and depression

Review of research progress on intestinal microbiota based on metabolism and inflammation for depression

Research Progress on Natural Compounds Exerting an Antidepressant Effect through Anti-inflammatory

Research status of neuro-immunological targets in pathogenesis of depression

Immunotherapy for depression: Recent insights and future targets

Neuroinflammation and depression: A review

Microglia Sing the Prelude of Neuroinflammation-Associated Depression

Research progress on the relationship between tachykinin/ tachykinin receptors and depression

Gut-brain axis in depression: Crosstalk between neuroinflammation and gut microbiota

A new perspective on depression and neuroinflammation: Non-coding RNA

Progress of Receptors, Cytokine and Signal Pathways about Depression

Research progress in depression related biomarkers based on omics technology

Neuroendocrine-immune Connection between Depression and Metabolic Syndrome

Common Cellular and Molecular Mechanisms and Interactions Between Microglial Activation and Aberrant Neuroplasticity in Depression